According to an August 2015 survey , 72 percent of Americans find drug costs unreasonable, with 83 percent believing that the federal government should be able to negotiate prices for Medicare. Recently, Acting Administrator of the Centers for Medicare
Read More...
Read the complete post at http://healthaffairs.org/blog/2016/05/03/a-controversial-new-demonstration-in-medicare-potential-implications-for-physician-administered-drugs/
Posted
May 03 2016, 08:00 AM
by
Health Affairs BlogHealth Affairs Blog
Filed under: Medicare, Quality, Featured, Payment Policy, Costs and Spending, CMMI, Medicare Part B, prescription drug coverage, Lucentis, oncology care model, Avastin